ISLAMABAD: The National Health Services (NHS) minister, Saira Afzal Tarar, in a letter to the Senate Standing Committee on Commerce has suggested that the ministry’s views should also be heard while discussing issues relating to medicines.
The letter has been written after a meeting of the standing committee on July 28, in which a number of departments, criticized Drug Regulatory Authority of Pakistan (Drap) for being hurdle to medicines exports.
The Chairman Standing Committee Syed Shibli Faraz, who belongs to PTI, told Dawn that principally ministry of NHS should have been invited but the meeting was called to discuss various options aimed at increasing the exports by different sectors but we learnt that Drug Regulatory Authority of Pakistan was the biggest hurdle in increasing the exports of medicines.
In the letter available with Dawn Ms Tarar has stated that no representative of the ministry was invited to the meeting to present the ministry’s point of view and verify genuineness of claims that Drap was main hurdle to medicines exports.
Mr Faraz said that though manufacturers were of the view that Drug Regulatory Authority of Pakistan was the major hurdle in increasing the exports of medicines, it has been decided to call the ministry’s representative to the next meeting to hear their point of view.
Apr 03, 2017 0